MicroRNA expression profile of surgical removed mandibular bone tissues from patients with mandibular prognathism

Yulou Tian1, Jie Liu2, Xiaofeng Bai3

  • 1Department of Orthodontics, School of Stomatology, China Medical University, Shenyang, People's Republic of China; Department of Orthodontics, Liaoning Institute of Dental Research, Shenyang, People's Republic of China.

Abstract

Insights

This study identified specific microRNAs (miRNAs) differentially expressed in mandibular bone tissue of patients with mandibular prognathism (MP). These findings suggest miRNAs play a role in MP pathogenesis, requiring further validation.

Area of Science:

  • Oral and Maxillofacial Surgery
  • Molecular Biology
  • Genetics

Background:

  • Mandibular prognathism (MP), a severe facial deformity, involves a prognathic mandible.
  • Recent research suggests circulating microRNAs (miRNAs) are linked to MP.
  • This study investigates miRNA expression in mandibular bone tissue from MP patients.

Purpose of the Study:

  • To characterize the miRNA expression profile in surgically removed mandibular bone tissue of MP patients.
  • To explore the role of miRNA regulation in the pathogenesis of MP.
  • To identify potential miRNA-gene interactions in MP.

Main Methods:

  • Utilized Affymetrix GeneChip miRNA 3.0 Array to analyze miRNA expression in MP and control bone tissues.
  • Employed bioinformatic approaches to predict miRNA target genes and their functions.
  • Constructed a miRNA-gene network to identify key regulatory interactions.

Main Results:

  • Identified 11 upregulated and 11 downregulated miRNAs in MP bone specimens (fold change ≥ 2, P < 0.05).
  • Predicted 3569 target genes for several key miRNAs, including hsa-miR-30 d-5p.
  • Target genes are involved in osteogenesis-related biological functions and signaling pathways, with hsa-miR-30 d-5p as a central network node.

Conclusions:

  • Differentially expressed miRNAs are potentially associated with mandibular prognathism pathogenesis.
  • Further research is required to validate the precise molecular mechanisms involved.
  • Identified key miRNAs and their target genes offer insights into MP development.